HUP0100095A2 - Kettős kapszula hatóanyagok adagolására többhatóanyagos terápiában - Google Patents

Kettős kapszula hatóanyagok adagolására többhatóanyagos terápiában

Info

Publication number
HUP0100095A2
HUP0100095A2 HU0100095A HUP0100095A HUP0100095A2 HU P0100095 A2 HUP0100095 A2 HU P0100095A2 HU 0100095 A HU0100095 A HU 0100095A HU P0100095 A HUP0100095 A HU P0100095A HU P0100095 A2 HUP0100095 A2 HU P0100095A2
Authority
HU
Hungary
Prior art keywords
capsule
active
administration
dosage form
double
Prior art date
Application number
HU0100095A
Other languages
English (en)
Inventor
Giovanni Sanso
Original Assignee
Axcan Pharma Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11378381&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUP0100095(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Axcan Pharma Inc. filed Critical Axcan Pharma Inc.
Publication of HUP0100095A2 publication Critical patent/HUP0100095A2/hu
Publication of HUP0100095A3 publication Critical patent/HUP0100095A3/hu
Publication of HU225690B1 publication Critical patent/HU225690B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

A találmány tárgya olyan gyógyszeradagoló forma, amely különösenalkalmas hatóanyagoknak az adagolására több hatóanyagos terápiáseljárásokban. Ez a gyógyszeradagoló forma kettős kapszula, ahol egybelső kapszulát egy külső kapszulába helyeznek. Mind a külső, mind abelső kapszula egy vagy több hatóanyagot tartalmaz. Egy találmányszerinti kettős kapszula előnyösen alkalmazható három hatóanyagos vagynégy hatóanyagos terápiában a Helicobacter pylori mikroorganizmusokellen. A találmány egyik előnyös kiviteli formájában agyógyszeradagoló forma áll egy külső kapszulából, amely bizmut-szubcitrátot és metronidazolt tartalmaz; valamint egy belsőkapszulából, amely tetraciklint és adott esetben omeprazolt tartalmaz,melyet a Helicobacter pylori kiirtását eredményező terápiábanalkalmaznak. Ó
HU0100095A 1997-12-17 1998-12-14 A double capsule for the administration of active principles in multiple therapies HU225690B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT97MI002788A IT1296980B1 (it) 1997-12-17 1997-12-17 Capsula doppia come forma farmaceutica per la somministrazione di principi attivi in terapie multiple
PCT/EP1998/008167 WO1999030693A2 (en) 1997-12-17 1998-12-14 A double capsule for the administration of active principles in multiple therapies

Publications (3)

Publication Number Publication Date
HUP0100095A2 true HUP0100095A2 (hu) 2001-06-28
HUP0100095A3 HUP0100095A3 (en) 2001-12-28
HU225690B1 HU225690B1 (en) 2007-06-28

Family

ID=11378381

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0100095A HU225690B1 (en) 1997-12-17 1998-12-14 A double capsule for the administration of active principles in multiple therapies

Country Status (26)

Country Link
US (1) US6350468B1 (hu)
EP (1) EP1037614B1 (hu)
JP (1) JP4615713B2 (hu)
KR (1) KR100509351B1 (hu)
CN (1) CN1147292C (hu)
AR (1) AR014126A1 (hu)
AT (1) ATE254910T1 (hu)
AU (1) AU743090B2 (hu)
BR (1) BR9812803A (hu)
CA (1) CA2315408C (hu)
CZ (1) CZ299181B6 (hu)
DE (1) DE69820108T2 (hu)
DK (1) DK1037614T3 (hu)
ES (1) ES2212391T3 (hu)
HK (1) HK1034897A1 (hu)
HU (1) HU225690B1 (hu)
ID (1) ID26340A (hu)
IT (1) IT1296980B1 (hu)
MY (1) MY121713A (hu)
NO (1) NO329126B1 (hu)
NZ (1) NZ505655A (hu)
PE (1) PE20000512A1 (hu)
PL (1) PL192541B1 (hu)
PT (1) PT1037614E (hu)
TR (1) TR200001761T2 (hu)
WO (1) WO1999030693A2 (hu)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6428809B1 (en) 1999-08-18 2002-08-06 Microdose Technologies, Inc. Metering and packaging of controlled release medication
WO2002007710A2 (en) * 2000-07-20 2002-01-31 Mw Encap Limited Delivery device
GB0017673D0 (en) * 2000-07-20 2000-09-06 Mw Encap Limited Delivery device
US20040131670A1 (en) * 2001-04-17 2004-07-08 Ping Gao Pellicle-resistant gelatin capsule
US20040105885A1 (en) * 2001-04-17 2004-06-03 Ping Gao Gelatin capsule exhibiting reduced cross-linking
US20040105883A1 (en) * 2001-04-17 2004-06-03 Ping Gao Pharmaceutical dosage form capable of maintaining stable dissolution profile upon storage
US20070087048A1 (en) * 2001-05-31 2007-04-19 Abrams Andrew L Oral dosage combination pharmaceutical packaging
US6726809B2 (en) * 2001-09-26 2004-04-27 Albany International Corp. Industrial process fabric
US7670612B2 (en) * 2002-04-10 2010-03-02 Innercap Technologies, Inc. Multi-phase, multi-compartment capsular delivery apparatus and methods for using same
AU2003290377A1 (en) * 2003-01-03 2004-07-29 Marton Milankovits Pharmaceutical compositions comprising an antibacterial agent nd antifungal agent and a nitroimidazole for the treatment and prevention of genitourinary infections and their extragenital complications
US20050053648A1 (en) * 2003-09-08 2005-03-10 Chalmers Anne Marie Medication delivery device
EP1682063A1 (en) * 2003-10-21 2006-07-26 Ambo Innovation LLC Digestible and volume adjustable multi medication delivery device
US7803817B2 (en) * 2005-05-11 2010-09-28 Vecta, Ltd. Composition and methods for inhibiting gastric acid secretion
US7981908B2 (en) * 2005-05-11 2011-07-19 Vecta, Ltd. Compositions and methods for inhibiting gastric acid secretion
CN100350900C (zh) * 2005-05-23 2007-11-28 江西本草天工科技有限责任公司 复方降香双相胶囊及其制备方法
CN100350899C (zh) * 2005-05-23 2007-11-28 江西本草天工科技有限责任公司 冠心丹参双相胶囊及其制备方法
CN100350898C (zh) * 2005-05-23 2007-11-28 江西本草天工科技有限责任公司 复方三七双相胶囊及其制备方法
US8865197B2 (en) * 2005-09-06 2014-10-21 Israel Oceanographic And Limnological Research Ltd. Food formulation for aquatic animals with integrated targeted delivery of bioactive agents
JP2009511191A (ja) * 2005-10-14 2009-03-19 マイクロドース・テクノロジーズ・インコーポレーテッド 経口投与剤組合せ型医薬パッケージ法
CN100393359C (zh) * 2005-12-13 2008-06-11 济南百诺医药科技开发有限公司 根除幽门螺旋杆菌的多单元组合物
US8784886B2 (en) * 2006-03-09 2014-07-22 GlaxoSmithKline, LLC Coating capsules with active pharmaceutical ingredients
EP2081550B2 (en) 2006-03-09 2021-05-26 Reliant Pharmaceuticals, Inc. Coating capsules with active pharmaceutical ingredients
RU2467747C2 (ru) * 2006-07-25 2012-11-27 Векта Лтд. Композиции и способы для ингибирования секреции желудочной кислоты с использованием производных малых дикарбоновых кислот в сочетании с ppi
US20090087483A1 (en) * 2007-09-27 2009-04-02 Sison Raymundo A Oral dosage combination pharmaceutical packaging
US8439033B2 (en) 2007-10-09 2013-05-14 Microdose Therapeutx, Inc. Inhalation device
CN101513395B (zh) * 2008-02-20 2011-01-12 单宝华 紫杉醇类双层软胶囊口服制剂药物
DE102009001334B4 (de) 2009-03-04 2017-02-23 Stefan Brosig Einfache magensaftresistente Verkapselung, z.B. von Ingwer und anderen empfindlichen Stoffen
CN101607086B (zh) * 2009-07-21 2011-11-02 山西安特生物制药股份有限公司 一种复方铋剂组合物及其制备方法
TWI463998B (zh) * 2009-12-31 2014-12-11 Synmosa Biopharma Corp Amoxicillin and clomycin have a high absorption rate of pharmaceutical ingredients
CN105381524A (zh) 2010-01-05 2016-03-09 微剂量治疗技术公司 吸入设备和方法
CN102349887A (zh) * 2011-08-02 2012-02-15 天津市嵩锐医药科技有限公司 双氯芬酸钠对乙酰氨基酚胃肠型胶囊药物组合物
ITMI20120350A1 (it) * 2012-03-06 2013-09-07 Ultimate Italia S A S Di Levantino Enrico E C Forma di dosaggio per somministrazione orale di principi attivi
US20160008371A1 (en) * 2014-07-14 2016-01-14 Autotelic Llc Fixed dose combination for pain relief without edema
US9700514B1 (en) * 2014-08-20 2017-07-11 Darren Rubin Single solid oral dosage forms for treating Helicobacter pylori infection and duodenal ulcer disease
CN105106162A (zh) * 2015-08-21 2015-12-02 四川百利药业有限责任公司 一种治疗幽门螺杆菌所引起溃疡的复方片剂及其制备方法
WO2017223043A1 (en) * 2016-06-22 2017-12-28 University Of Florida Research Foundation, Inc. Pharmaceutical capsules for medication adherence monitoring and methods of forming the same
CN108186968B (zh) * 2018-01-08 2021-07-20 江苏聚荣制药集团有限公司 温胃舒胶囊

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB825480A (en) 1957-07-13 1959-12-16 Johann Carl Pflueger Improvements in or relating to ingestible dry micro-organism preparations and method for producing the same
FR1454013A (fr) * 1965-08-18 1966-07-22 Pluripharm Mode de présentation de deux médicaments associés
DE2729068A1 (de) 1977-06-28 1979-01-11 Rainer Dr Med Liedtke Verfahren zur freisetzungssteuerung von arzneimitteln aus kapseln
CA1143287A (en) * 1981-08-11 1983-03-22 William C. Stewart Waterproof edible encapsulation for prophylactic drugs
DK150008C (da) 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
US4642233A (en) 1982-03-22 1987-02-10 Alza Corporation Gastrointestinal drug delivery system comprising a hydrogel reservoir containing a plurality of tiny pills
FR2524311A1 (fr) * 1982-04-05 1983-10-07 Azalbert Gilles Gelule compartimentee aux fins d'ingestions simultanees a effets differes
JPS59131355A (ja) 1983-01-17 1984-07-28 森下仁丹株式会社 多重軟カプセルの製法
JPS60193917A (ja) * 1984-03-14 1985-10-02 R P Shiila- Kk 多重構造軟カプセル剤
US4627808A (en) 1985-05-31 1986-12-09 Hughes Raymond J Apparatus for making capsule having plural chambers
US5256684A (en) 1985-06-13 1993-10-26 The Procter & Gamble Company Methods and compositions for the treatment of gastrointestinal disorders
US4904476A (en) 1986-03-04 1990-02-27 American Home Products Corporation Formulations providing three distinct releases
US4793493A (en) 1986-09-18 1988-12-27 Makiej Jr Walter J Multidose capsules
US4936461A (en) 1986-09-18 1990-06-26 Makiej Jr Walter J Multidose capsules
US4822619A (en) 1987-02-18 1989-04-18 Ionor, Inc. Controlled release pharmaceutical preparation containing a gastrointestinal irritant drug
US5394980A (en) 1987-06-30 1995-03-07 Tsai; Min H. Multicompartment mixing capsule
EP0439453B1 (en) 1987-10-12 1994-01-19 Exomed Australia Pty. Ltd. (ACN 051 976 446) Improved method for treatment of gastrointestinal disorders
US5192752A (en) 1991-01-14 1993-03-09 The Procter & Gamble Company Swallowable pharmaceutical compositions containing colloidal bismuth subcitrate
GB9120131D0 (en) * 1991-09-20 1991-11-06 Glaxo Group Ltd Medicaments
US5582837A (en) 1992-03-25 1996-12-10 Depomed, Inc. Alkyl-substituted cellulose-based sustained-release oral drug dosage forms
US5472695A (en) 1992-06-25 1995-12-05 Technion Research And Development Foundation Ltd. Therapeutic application of a thyme extract and in - vitro methods for inhibiting the growth and urease activity of helicobacter pylori
US5310555A (en) 1992-07-24 1994-05-10 Midwestern Bio-Ag Products And Services, Inc. Oral nutritional and dietary composition
US5501857A (en) * 1992-07-24 1996-03-26 Midwestern Bio-Ag Products & Services, Inc. Oral nutritional and dietary composition
PL176846B1 (pl) * 1993-02-26 1999-08-31 Procter & Gamble Kompozycja farmaceutyczna w jednostkowej postaci dawkowania do doustnego podawania bisakodylu
AU7966694A (en) 1993-07-21 1996-05-02 University Of Kentucky Research Foundation, The A multicompartment hard capsule with control release properties
US5560912A (en) 1994-06-27 1996-10-01 Technion Research & Development Foundation Ltd. Method for inhibiting growth of helicobacter pylori
AUPM695294A0 (en) 1994-07-20 1994-08-11 Borody, Thomas Julius Improved combination therapy dose unit

Also Published As

Publication number Publication date
ES2212391T3 (es) 2004-07-16
NZ505655A (en) 2003-09-26
PL341737A1 (en) 2001-05-07
DK1037614T3 (da) 2004-04-05
EP1037614A2 (en) 2000-09-27
CZ20002231A3 (cs) 2000-11-15
IT1296980B1 (it) 1999-08-03
AU2413599A (en) 1999-07-05
CA2315408A1 (en) 1999-06-24
AR014126A1 (es) 2001-02-07
JP2002508312A (ja) 2002-03-19
HK1034897A1 (en) 2001-11-09
DE69820108T2 (de) 2004-09-09
HUP0100095A3 (en) 2001-12-28
KR20010033244A (ko) 2001-04-25
BR9812803A (pt) 2000-10-03
JP4615713B2 (ja) 2011-01-19
CZ299181B6 (cs) 2008-05-14
ATE254910T1 (de) 2003-12-15
ITMI972788A1 (it) 1999-06-17
HU225690B1 (en) 2007-06-28
KR100509351B1 (ko) 2005-08-22
CA2315408C (en) 2005-05-24
TR200001761T2 (tr) 2000-10-23
NO20003159L (no) 2000-08-16
MY121713A (en) 2006-02-28
WO1999030693A2 (en) 1999-06-24
ID26340A (id) 2000-12-14
NO329126B1 (no) 2010-08-30
CN1147292C (zh) 2004-04-28
US6350468B1 (en) 2002-02-26
NO20003159D0 (no) 2000-06-16
PL192541B1 (pl) 2006-11-30
PE20000512A1 (es) 2000-06-13
PT1037614E (pt) 2004-04-30
CN1285741A (zh) 2001-02-28
DE69820108D1 (de) 2004-01-08
WO1999030693A3 (en) 1999-09-02
EP1037614B1 (en) 2003-11-26
AU743090B2 (en) 2002-01-17

Similar Documents

Publication Publication Date Title
HUP0100095A2 (hu) Kettős kapszula hatóanyagok adagolására többhatóanyagos terápiában
Brand et al. Drugs used in motion sickness. A critical review of the methods available for the study of drugs of potential value in its treatment and of the information which has been derived by these methods
HUP0004625A1 (hu) Az emésztőcsatorna felső szakaszának fokozott biztonságot nyújtó filmbevonatos tabletta
HUP9801283A2 (hu) Tomoxetin alkalmazása figyelemhiány/hiperaktivitás betegség kezelésére alkalmas gyógyszerkészítmény előállítására
WO2006022996A3 (en) Dosage form containing multiple drugs
MX9604354A (es) Nueva forma de dosis farmaceutica oral.
HUP0201877A2 (hu) Hal zselatint tartalmazó, gyorsan diszpergálódó dózis formák
ATE277594T1 (de) Vorrichtungen um eine verlängerte medikamententherapie zu erreichen
ATE232100T1 (de) Gegen magensaft geschützte omeprazol- mikrogranülen, herstellungsverfahren und pharmazeutische zubereitungen
AU1227899A (en) Osmotic medicament releasing system
EP1243267A3 (en) Amoxycillin and clavulanate containing pharmaceutical formulation
SE9700885D0 (sv) New pharmaceutical formulation
IL154731A0 (en) Ion-strength independent sustained release pharmaceutical formulation
NO20101070L (no) Fremgangsmate til dosering av et medikament, samt doseringsform
UA32457C2 (uk) Лікарський засіб (варіанти) і спосіб медикаментозного впливу на організм
HUP9901935A2 (hu) Gyógyszerek és terápiás szerek és más glikozaminoglikánok (GAG) dózisainak célbajuttatására alkalmas dóziskészlet
Giunchi et al. Trimethoprim-sulfamethoxazole combination in the treatment of acute human brucellosis.
HUP0300717A2 (hu) Mirtazapint és paracetamolt vagy nem szteroid gyulladáscsökkentő gyógyszert tartalmazó gyógyszerkombináció fejfájás kezelésére
NO953003L (no) Anvendelse av ifenprodil og diastereoisomerer derav for fremstilling av medisinske preparater
RU2003133155A (ru) Способ эрадикации инфекции helicobacter pylori в желудке
NO20032799D0 (no) Nye terapeutiske anvendelser av tienylsykloheksylamin- derivater
RU99127981A (ru) Способ лечения рецидивирующего фурункулеза
HUP0104941A2 (hu) Több gyógyszerformát tartalmazó bliszter
Miller Triple-drug capsule for eradicating H. pylori infection
MX2016003209A (es) Composicion farmaceutica para el tratamiento de helicobacter pylori que contiene dos antibioticos y un inhibidor de la bomba de protones.

Legal Events

Date Code Title Description
HC9A Change of name, address

Owner name: APTALIS PHARMA CANADA INC., CA

Free format text: FORMER OWNER(S): AXCAN PHARMA INC., CA